Connor, Clark & Lunn Investment Management (CC&L)’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $397K | Sell |
|
|||||
|
2024
Q1 | $1.3M | Buy |
|
|||||
|
2023
Q4 | $148K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $2.94M | Buy |
|
|||||
|
2022
Q2 | $2.79M | Buy |
|
|||||
|
2022
Q1 | $3.47M | Buy |
|
|||||
|
2021
Q4 | $1.96M | Sell |
|
|||||
|
2021
Q3 | $4.97M | Buy |
|
|||||
|
2021
Q2 | $6.03M | Buy |
|
|||||
|
2021
Q1 | $2.48M | Buy |
|